MID-VOLUME · HOSP-HEAVY
ranolazine Side Effects
ranolazine (also sold as Ranexa) sits MID-VOLUME #318 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 43.1% mention hospitalization (4,313 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 10,014
- FAERS reports
FDA Adverse Event Reporting System extract for ranolazine. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
ranolazine: 43.1% mention hospitalization (4,313 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #318 of 524 by FAERS report count.
Mid-book FAERS page for ranolazine (Ranexa) (10,014 reports). Signature HOSP-HEAVY. Dominant age band on file: 75+. Educational reference only.
Counts from the openFDA FAERS extract (2005–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
DEATH leads 816 of 10,014 reports
Who reports · age peak 75+ (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 75+ (3,280 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (1,295 reports, 12.9%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 810 |
| COMPLETED SUICIDE | 90 |
| CARDIAC ARREST | 61 |
| CARDIAC FAILURE | 49 |
| TOXICITY TO VARIOUS AGENTS | 48 |
| CARDIAC FAILURE CONGESTIVE | 42 |
| MYOCARDIAL INFARCTION | 40 |
| HYPOTENSION | 33 |
| FALL | 30 |
| PNEUMONIA | 30 |
| BRADYCARDIA | 28 |
| INTENTIONAL OVERDOSE | 27 |
| ELECTROCARDIOGRAM QT PROLONGED | 26 |
| DYSPNOEA | 25 |
| PULMONARY OEDEMA | 25 |
| SOMNOLENCE | 25 |
| HYPERHIDROSIS | 24 |
| PULSELESS ELECTRICAL ACTIVITY | 23 |
| CARDIAC DISORDER | 22 |
| HYPOXIA | 21 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (4,313, 43.1% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| CHEST PAIN | 407 |
| MYOCARDIAL INFARCTION | 384 |
| STENT PLACEMENT | 329 |
| DYSPNOEA | 246 |
| FALL | 243 |
| ANGINA PECTORIS | 188 |
| DIZZINESS | 180 |
| CEREBROVASCULAR ACCIDENT | 174 |
| CARDIAC DISORDER | 164 |
| PNEUMONIA | 157 |
| DRUG INTERACTION | 156 |
| MALAISE | 143 |
| CARDIAC FAILURE CONGESTIVE | 130 |
| HYPOTENSION | 130 |
| NAUSEA | 117 |
| CARDIAC OPERATION | 116 |
| ASTHENIA | 104 |
| FATIGUE | 98 |
How to read ranolazine FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 10,014 voluntary reports linked to ranolazine (Ranexa), 2005-2025. Death is listed on 1,295 (12.9%). Hospitalization appears on 4,313 (43.1%). Top co-reported indication: Angina Pectoris.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 43.1% mention hospitalization (4,313 reports).
Read with ranolazine
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 9,944 FAERS cases (Δ 70 lighter vs ranolazine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 9,899 FAERS cases (Δ 115 lighter vs ranolazine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 9,877 FAERS cases (Δ 137 lighter vs ranolazine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 10,198 FAERS cases (Δ 184 heavier vs ranolazine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 49.2 pp vs ranolazine's DEATH-HEAVY): CASELOAD · HOSP-MID.
ranolazine stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.